youtube_live
Q3 2026 earnings • released • EPS beat +7,77% • Revenue beat +2,95%
See resultschevron_right
GH:NASDAQ
Guardant Health Inc
US$153,43
0,00%
(0,00) 1D
US$142,00
arrow_downward
-7,45% (-11,43)todayPre-market
Closed: 5 ພ.ຈ., 16 ໂມງ 0 ນາທີ 02 ວິນາທີ GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GH...
Mkt. cap
20,59 ຕື້
Avg. vol.
1,86 ລ້ານ
Volume
36,29 ພັນ
52-wk high
US$191,05
52-wk low
US$74,55
EPS
US$-3,50
Beta
1,67
Shares outstanding
134,20 ລ້ານ
No. of employees
2 ພັນ
Mkt. cap
20,59 ຕື້
Avg. vol.
1,86 ລ້ານ
Volume
36,29 ພັນ
52-wk high
US$191,05
52-wk low
US$74,55
EPS
US$-3,50
Beta
1,67
Shares outstanding
134,20 ລ້ານ
No. of employees
2 ພັນ
News stories
From web sources and news partners
Investing.com
·
2 ຊົ່ວໂມງກ່ອນ
Guardant Health stock reiterated at Buy by BTIG after Q3 beat
Yahoo Finance Singapore
·
8 ຊົ່ວໂມງກ່ອນ
Guardant Health Inc (GH) (Q3 2026) Earnings Call Highlights: Revenue Surges 36% as Shield ...
GenomeWeb
·
12 ຊົ່ວໂມງກ່ອນ
Guardant Health Q3 Revenue Climbs 36 Percent as Firm Raises Full-Year Guidance
Zacks
·
13 ຊົ່ວໂມງກ່ອນ
Guardant Health (GH) Reports Q3 Loss, Tops Revenue Estimates
Profile
Guardant Health, Inc. is an American biotechnology company based in Palo Alto, California. Co-founders Helmy Eltoukhy and AmirAli Talasaz serve as co-chief executive officers. Wikipedia
About Guardant Health Inc
CEOHelmy Eltoukhy | AmirAli Talasaz
Employees2,5 ພັນ
Founded2012
HeadquartersPalo Alto, ແຄລິຟໍເນຍ, ສະຫະລັດ
SectorHealth Care
IndustryHealth care provider
Websiteguardanthealth.com